Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 23;25(8):255.
doi: 10.1208/s12249-024-02970-z.

Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls

Affiliations

Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls

Jayshil A Bhatt et al. AAPS PharmSciTech. .

Abstract

The rapid progress in artificial intelligence (AI) has revolutionized problem-solving across various domains. The global challenge of pharmaceutical product recalls imposes the development of effective tools to control and reduce shortage of pharmaceutical products and help avoid such recalls. This study employs AI, specifically machine learning (MI), to analyze critical factors influencing formulation, manufacturing, and formulation complexity which could offer promising avenue for optimizing drug development processes. Utilizing FDAZilla and SafeRX tools, an open database model was constructed, and predictive statistical models were developed using Multivariate Analysis and the Least Absolute Shrinkage and Selection Operator (LASSO) Approach. The study focuses on key descriptors such as delivery route, dosage form, dose, BCS classification, solid-state and physicochemical properties, release type, half-life, and manufacturing complexity. Through statistical analysis, a data simplification process identifies critical descriptors, assigning risk numbers and computing a cumulative risk number to assess product complexity and recall likelihood. Partial Least Square Regression and the LASSO approach established quantitative relationships between key descriptors and cumulative risk numbers. Results have identified key descriptors; BCS Class I, dose number, release profile, and drug half-life influencing product recall risk. The LASSO model further confirms these identified descriptors with 71% accuracy. In conclusion, the study presents a holistic AI and machine learning approach for evaluating and forecasting pharmaceutical product recalls, underscoring the importance of descriptors, formulation complexity, and manufacturing processes in mitigating risks associated with product quality.

Keywords: artificial intelligence; drug quality control; machine learning; multivariate analysis; pharmaceutical recalls; predictive modeling.

PubMed Disclaimer

Similar articles

References

    1. Huggins CJPT. Drug recalls are more widespread than previously thought. Pharm Today. 2019;25(3):4. - DOI
    1. Wang B, Gagne JJ, Choudhry NK. The epidemiology of drug recalls in the United States. Arch Intern Med. 2012;172(14):1110–1. - DOI
    1. Sultan T, Rozin EH, Dave VS, Cetinkaya C. Non-destructive detection of disintegrant levels in compressed oral solid dosage forms. Int J Pharma. 2023;642:123171. - DOI
    1. Shah R, Ball GP, Netessine S. Plant operations and product recalls in the automotive industry: an empirical investigation. Manag Sci. 2017;63(8):2439–59. - DOI
    1. Hall K, Stewart T, Chang J, Freeman MK. Characteristics of FDA drug recalls: a 30-month analysis. Am J Health Syst Pharm. 2016;73(4):235–40. - PubMed - DOI

Substances

LinkOut - more resources